Should we start population screening for prostate cancer? Randomised trials are still needed.
Auvinen
Anssi
A
School of Public Health, FIN-33014 University of Tampere, Tampere, Finland. aussi.auvinen@uta.fi
Alexander
Freda E
FE
de Koning
Harry J
HJ
Miller
Anthony B
AB
D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D013997:Time Factors
D017430:Prostate-Specific Antigen